Carolyn Dicus Brookes1, John Berry2, Josiah Rich3, Brent A Golden4, Timothy A Turvey5, George Blakey6, Vincent Kopp7, Ceib Phillips8, Jay Anderson9. 1. Chief Resident, Department of Oral and Maxillofacial Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC. 2. Chief Resident, Department of Anesthesiology, University of North Carolina at Chapel Hill, Chapel Hill, NC. 3. Research Associate, Department of Orthodontics, University of North Carolina at Chapel Hill, Chapel Hill, NC. 4. Clinical Assistant Professor, Department of Oral and Maxillofacial Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC. 5. Professor and Chairman, Department of Oral and Maxillofacial Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC. 6. Raymond P. White Distinguished Associate Professor and Program Director, Department of Oral and Maxillofacial Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC. 7. Professor, Department of Anesthesiology, University of North Carolina at Chapel Hill, Chapel Hill, NC. 8. Professor, Department of Orthodontics, University of North Carolina at Chapel Hill, Chapel Hill, NC. 9. Associate Professor, Departments of Anesthesiology and Oral and Maxillofacial Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC. Electronic address: janderson@aims.unc.edu.
Abstract
PURPOSE: To assess the impact of a multimodal antiemetic protocol on postoperative nausea and vomiting (PONV) after Le Fort I osteotomy. MATERIALS AND METHODS: Consecutive patients undergoing Le Fort I osteotomy with or without additional procedures at a single academic institution were recruited as the intervention cohort for an institutional review board-approved prospective clinical trial with a retrospective comparison group. The intervention cohort was managed with a multimodal antiemetic protocol, including total intravenous anesthesia; prophylactic ondansetron, steroids, scopolamine, and droperidol; gastric decompression at surgery end; opioid-sparing analgesia; avoidance of morphine and codeine; prokinetic erythromycin; and fluids at a minimum of 25 mL/kg. The comparison group consisted of consecutive patients from a larger study who underwent similar surgical procedures before protocol implementation. Data, including occurrence of PONV, were extracted from medical records. Data were analyzed in bivariate fashion with the Fisher exact and Wilcoxon rank-sum tests. Logistic regression was used to compare the likelihood of nausea and vomiting in the 2 cohorts after controlling for demographic and surgical characteristics. A P value less than .05 was considered significant. RESULTS: The intervention (n = 93) and comparison (n = 137) groups were similar in gender (58% and 65% female patients; P = .29), race (72% and 71% Caucasian; P = .85), age (median, 19 and 20 years old; P = .75), proportion of patients with known risk factors for PONV (P = .34), percentage undergoing bimaxillary surgery (60% for the 2 groups), and percentage for whom surgery time was longer than 180 minutes (63% and 59%; P = .51). Prevalence of postoperative nausea was significantly lower in the intervention group than in the comparison group (24% vs 70%; P < .0001). Prevalence of postoperative vomiting was likewise significantly lower in the intervention group (11% vs 28%; P = .0013). The likelihood that patients in the comparison group would develop nausea was 8.9 and that for vomiting was 3.7 times higher than in the intervention group. CONCLUSION: This multimodal protocol was associated with substantially decreased prevalence of PONV in patients undergoing Le Fort I osteotomy. Published by Elsevier Inc.
PURPOSE: To assess the impact of a multimodal antiemetic protocol on postoperative nausea and vomiting (PONV) after Le Fort I osteotomy. MATERIALS AND METHODS: Consecutive patients undergoing Le Fort I osteotomy with or without additional procedures at a single academic institution were recruited as the intervention cohort for an institutional review board-approved prospective clinical trial with a retrospective comparison group. The intervention cohort was managed with a multimodal antiemetic protocol, including total intravenous anesthesia; prophylactic ondansetron, steroids, scopolamine, and droperidol; gastric decompression at surgery end; opioid-sparing analgesia; avoidance of morphine and codeine; prokinetic erythromycin; and fluids at a minimum of 25 mL/kg. The comparison group consisted of consecutive patients from a larger study who underwent similar surgical procedures before protocol implementation. Data, including occurrence of PONV, were extracted from medical records. Data were analyzed in bivariate fashion with the Fisher exact and Wilcoxon rank-sum tests. Logistic regression was used to compare the likelihood of nausea and vomiting in the 2 cohorts after controlling for demographic and surgical characteristics. A P value less than .05 was considered significant. RESULTS: The intervention (n = 93) and comparison (n = 137) groups were similar in gender (58% and 65% female patients; P = .29), race (72% and 71% Caucasian; P = .85), age (median, 19 and 20 years old; P = .75), proportion of patients with known risk factors for PONV (P = .34), percentage undergoing bimaxillary surgery (60% for the 2 groups), and percentage for whom surgery time was longer than 180 minutes (63% and 59%; P = .51). Prevalence of postoperative nausea was significantly lower in the intervention group than in the comparison group (24% vs 70%; P < .0001). Prevalence of postoperative vomiting was likewise significantly lower in the intervention group (11% vs 28%; P = .0013). The likelihood that patients in the comparison group would develop nausea was 8.9 and that for vomiting was 3.7 times higher than in the intervention group. CONCLUSION: This multimodal protocol was associated with substantially decreased prevalence of PONV in patients undergoing Le Fort I osteotomy. Published by Elsevier Inc.
Authors: J T Fortney; T J Gan; S Graczyk; B Wetchler; T Melson; S Khalil; R McKenzie; S Parrillo; P S Glass; C Moote; D Wermeling; T V Parasuraman; B Duncan; M R Creed Journal: Anesth Analg Date: 1998-04 Impact factor: 5.108
Authors: Alan N Barkun; Marc Bardou; Ernst J Kuipers; Joseph Sung; Richard H Hunt; Myriam Martel; Paul Sinclair Journal: Ann Intern Med Date: 2010-01-19 Impact factor: 25.391
Authors: Swen N Piper; Kerstin Röhm; Joachim Boldt; Peter Kranke; Wolfgang Maleck; Rudolf Seifert; Stefan Suttner Journal: J Craniomaxillofac Surg Date: 2008-03-18 Impact factor: 2.078
Authors: René Fernando Rodriguez; Javier Mauricio Castillo; Maria Del Pilar Castillo; Paola Daza Nuñez; Mario Fernando Rodriguez; José Manuel Restrepo; Jorge Martin Rodriguez; Yamileth Ortiz; Ana Maria Angel Journal: Clin Ther Date: 2007-04 Impact factor: 3.393
Authors: Carolyn Dicus Brookes; Timothy A Turvey; Ceib Phillips; Vincent Kopp; Jay A Anderson Journal: J Oral Maxillofac Surg Date: 2015-01-29 Impact factor: 1.895
Authors: S Samieirad; A Sharifian-Attar; M Eshghpour; V Mianbandi; E Shadkam; M Hosseini-Abrishami; M-S Hashemipour Journal: Med Oral Patol Oral Cir Bucal Date: 2018-11-01